In vitro induction of tumor-specific human lymphocyte antigen class I–restricted CD8+ cytotoxic T lymphocytes by ovarian tumor antigen–pulsed autologous dendritic cells from patients with advanced ovarian cancer

This publication has 15 references indexed in Scilit:

• Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression
  The Journal of Immunology, 2000
• Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts
  International Journal of Cancer, 1997
• Antigen‐presenting cells pulsed with unfractionated tumor‐derived peptides are potent tumor vaccines
  European Journal of Immunology, 1997
• Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
  The Journal of Experimental Medicine, 1996
• Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers
  International Journal of Cancer, 1996
• Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
  The Journal of Experimental Medicine, 1996
• Gradual Loss of T-Helper 1 Populations in Spleen of Mice During Progressive Tumor Growth
  JNCI Journal of the National Cancer Institute, 1995
• Shared T Cell Epitopes in Epithelial Tumors
  Cellular Immunology, 1995
• Identification of T-Cell Epitopes
  Journal of Immunotherapy, 1993
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991